Perceptive Advisors Llc Buys Landos Biopharma Inc, Prometheus Biosciences Inc, Prometheus Biosciences Inc, Sells Novavax Inc, Neurocrine Biosciences Inc, Eidos Therapeutics Inc

• New Purchases: LABP, RXDX, RXDX, EXAS, TARS, BEAM, ACAD, UTHR, NUVB, IMTX, ATEC, MREO, IMCR, ACRS, CMIIU, RACA, RACB, CLOV, XENE, CATB, DRIO, LGV.U, MRUS, TLIS, TXMD, CMLF, RGNX, PLXP, PHVS, CVM, SANA,
• Added Positions: BBIO, SWTX, MGNX, ALDX, MORF, RAPT, ESTA, SLDB, VERU, FBRX, HCAT, VYNE, DBVT, ATHA, VRCA, CERE, ISEE,
• Reduced Positions: NBIX, NVTA, HZNP, KOD, FOLD, ARWR, MRTX, FREQ, ADPT, NVRO, RCKT, OM, GBT, IOVA, PRVB, COLL, NEPT, RLAY, ACCD, CMPS, NARI, PMVP, SILK, HRMY, VRAY, FDMT, TARA, TVTX, AMWL, RNA, FUSN, TCRR, MOTS, CTMX, GRTX, SNDX, NBTX,
• Sold Out: NVAX, EIDX, IMVT, ZNTL, UROV, SAGE, LUNG, REGN, ANAB, NSTG, GERN, AMRS, WVE, RGEN, SCYX, SCPE.U, MRVI, CRIS, RVMD, SHC, DYN, AQST, PTGX, MASS, MTEM, AVXL, BNR, ADAP, LEGN, IPOF, ABCL,

For the details of PERCEPTIVE ADVISORS LLC's stock buys and sells, go to https://www.gurufocus.com/guru/perceptive+advisors+llc/current-portfolio/portfolio

1. Mirati Therapeutics Inc (MRTX) - 3,474,505 shares, 8.58% of the total portfolio. Shares reduced by 5.93%
2. BridgeBio Pharma Inc (BBIO) - 7,756,928 shares, 6.89% of the total portfolio. Shares added by 15.67%
3. SpringWorks Therapeutics Inc (SWTX) - 4,849,912 shares, 5.14% of the total portfolio. Shares added by 16.09%
4. Iovance Biotherapeutics Inc (IOVA) - 8,651,785 shares, 3.95% of the total portfolio. Shares reduced by 5.61%
5. Amicus Therapeutics Inc (FOLD) - 22,861,329 shares, 3.26% of the total portfolio. Shares reduced by 8.96%

Perceptive Advisors Llc initiated holding in Landos Biopharma Inc. The purchase prices were between $9.47 and $16.26, with an estimated average price of $13.05. The stock is now traded at around $11.820000. The impact to a portfolio due to this purchase was 2.3%. The holding were 17,960,839 shares as of 2021-03-31.

Perceptive Advisors Llc initiated holding in Prometheus Biosciences Inc. The purchase prices were between $16.51 and $25.29, with an estimated average price of $20.65. The stock is now traded at around $19.370000. The impact to a portfolio due to this purchase was 0.8%. The holding were 3,314,032 shares as of 2021-03-31.

Perceptive Advisors Llc initiated holding in Prometheus Biosciences Inc. The purchase prices were between $16.51 and $25.29, with an estimated average price of $20.65. The stock is now traded at around $19.370000. The impact to a portfolio due to this purchase was 0.8%. The holding were 3,314,032 shares as of 2021-03-31.

Perceptive Advisors Llc initiated holding in Exact Sciences Corp. The purchase prices were between $116.57 and $155.01, with an estimated average price of $137.18. The stock is now traded at around $96.580000. The impact to a portfolio due to this purchase was 0.67%. The holding were 353,523 shares as of 2021-03-31.

Perceptive Advisors Llc initiated holding in Tarsus Pharmaceuticals Inc. The purchase prices were between $27.37 and $47.25, with an estimated average price of $36.98. The stock is now traded at around $30.720000. The impact to a portfolio due to this purchase was 0.59%. The holding were 1,296,416 shares as of 2021-03-31.

Perceptive Advisors Llc initiated holding in Beam Therapeutics Inc. The purchase prices were between $71.28 and $120.75, with an estimated average price of $95.29. The stock is now traded at around $73.260000. The impact to a portfolio due to this purchase was 0.55%. The holding were 537,635 shares as of 2021-03-31.

Perceptive Advisors Llc added to a holding in Morphic Holding Inc by 92.64%. The purchase prices were between $29.77 and $84.85, with an estimated average price of $45.77. The stock is now traded at around $47.130000. The impact to a portfolio due to this purchase was 0.41%. The holding were 938,140 shares as of 2021-03-31.

Perceptive Advisors Llc added to a holding in Macrogenics Inc by 70.34%. The purchase prices were between $18.99 and $33.2, with an estimated average price of $24.22. The stock is now traded at around $30.770000. The impact to a portfolio due to this purchase was 0.41%. The holding were 2,148,060 shares as of 2021-03-31.

Perceptive Advisors Llc added to a holding in Aldeyra Therapeutics Inc by 38.48%. The purchase prices were between $6.53 and $14.42, with an estimated average price of $11.53. The stock is now traded at around $12.030000. The impact to a portfolio due to this purchase was 0.41%. The holding were 8,703,879 shares as of 2021-03-31.

Perceptive Advisors Llc added to a holding in RAPT Therapeutics Inc by 57.05%. The purchase prices were between $16 and $24.46, with an estimated average price of $20.63. The stock is now traded at around $23.060000. The impact to a portfolio due to this purchase was 0.29%. The holding were 2,477,481 shares as of 2021-03-31.

Perceptive Advisors Llc added to a holding in Establishment Labs Holdings Inc by 41.72%. The purchase prices were between $36 and $73.76, with an estimated average price of $57.87. The stock is now traded at around $72.200000. The impact to a portfolio due to this purchase was 0.26%. The holding were 987,287 shares as of 2021-03-31.

Perceptive Advisors Llc added to a holding in Solid Biosciences Inc by 24.15%. The purchase prices were between $5.37 and $10.72, with an estimated average price of $7.38. The stock is now traded at around $3.860000. The impact to a portfolio due to this purchase was 0.21%. The holding were 13,412,552 shares as of 2021-03-31.

Perceptive Advisors Llc sold out a holding in Novavax Inc. The sale prices were between $112.98 and $319.93, with an estimated average price of $200.73.

Perceptive Advisors Llc sold out a holding in Eidos Therapeutics Inc. The sale prices were between $117.32 and $128.51, with an estimated average price of $123.33.

Perceptive Advisors Llc sold out a holding in Immunovant Inc. The sale prices were between $13.08 and $49.6, with an estimated average price of $26.3.

Perceptive Advisors Llc sold out a holding in Zentalis Pharmaceuticals Inc. The sale prices were between $35.69 and $52.72, with an estimated average price of $42.95.

Perceptive Advisors Llc sold out a holding in Urovant Sciences Ltd. The sale prices were between $16.05 and $16.24, with an estimated average price of $16.18.

Perceptive Advisors Llc sold out a holding in Sage Therapeutics Inc. The sale prices were between $70.65 and $96.76, with an estimated average price of $82.06.